Evidence map›Paper›PMID 39676893›Full record

ArticleCurrent addiction reports2024

Use of Digital Health and Digital Therapeutics to Treat SUD in Criminal Justice Settings: a Review.

Ginnie Sawyer-Morris, Judith A Wilde, Todd Molfenter, Faye Taxman

Abstract read
In one paragraph

Article in Current addiction reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ginnie Sawyer-MorrisAddiction Policy Forum, 4701 Sangamore Rd, Ste 100N-1173, Bethesda, MD 20816, USA.
Judith A WildeSchar School of Policy and Government, George Mason University, 3351 Fairfax Drive, Arlington, VA 22201, USA.ORCID 0000-0003-1664-9552
Todd MolfenterCenter for Health Enhancement Studies, University of Wisconsin-Madison, 1513 University Avenue, Madison, WI 53706, USA.
Faye TaxmanSchar School of Policy and Government, George Mason University, 3351 Fairfax Drive, Arlington, VA 22201, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Technical Assistance CoreU2CDA050097 · NIDA · GEORGE MASON UNIVERSITY · PI Todd David Molfenter, Jessica Hulsey Nickel · 2019 to 2026
$37.0M
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance UptakeOT2OD034479 · OD · GEORGE MASON UNIVERSITY · PI TAXMAN, FAYE S · 2022 to 2023
$5.6M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS U2C DA050097NIH HHS OT2 OD034479
6 · The paper itself

Abstract

Purpose of Review: The purpose of this review is to investigate the use of digital health technologies and/or digital therapeutics (DTx) products in the treatment of substance use disorders (SUDs) in the general population and among criminal justice-involved individuals. Recent Findings: Despite an expanding evidence base, only three SUD DTxs have received federal regulatory approval. Across studies, DTx products have proven successful in engaging patients in SUD treatment and reducing healthcare costs and resource utilizations. Findings for emerging SUD DTx products show similar results. Still, there is a paucity of evidence regarding the use of digital health technologies and/or DTx among criminal justice populations. Summary: DTxs have proven effective for treating multiple SUD types (e.g., nicotine and opioids) among the general population. DTx shows similar promise among justice-involved populations, but additional efficacy and implementation research is needed to address barriers such as cost, cultural resistance, and infrastructure.

Indexed as

Criminal justice settingsDigital healthDigital therapeuticsOpioid use disorderSoftware as a medical deviceSubstance use disorder

Identifiers

PMID39676893
PMCPMC11643629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.